This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenqvist, E.
Right arrow Articles by Nokleby, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenqvist, E.
Right arrow Articles by Nokleby, H.

 Previous Article  |  Next Article 

Infect. Immun., 12 1995, 4642-4652, Vol 63, No. 12
Copyright © 1995, American Society for Microbiology

Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine

E Rosenqvist, EA Hoiby, E Wedege, K Bryn, J Kolberg, A Klem, E Ronnild, G Bjune and H Nokleby
Department of Vaccinology, National Institute of Public Health, Oslo, Norway.

The antibody kinetics in sera from 27 adults after three doses of the Norwegian group B meningococcal outer membrane vesicle (OMV) vaccine was studied. The vaccinees received the third dose 4 to 5 years after the first two. Antibody responses against outer membrane proteins (OMPs) and lipopolysaccharides were studied by enzyme-linked immunosorbent assay and immunoblotting and with serum bactericidal assays (SBA) with three variants of the vaccine strain, 44/76. Six weeks after the second injection, the geometric mean (GM) of the levels of immunoglobulin G (IgG) against OMVs was about sevenfold higher than that of prevaccination levels, and 74% of the vaccinees developed a greater-than-twofold rise in SBA titer. After 6 months, the GM of IgG levels declined to about threefold higher, and after 4 to 5 years it declined to about twofold higher, than that before vaccination. The third dose induced a rapid increase in SBA titers in 96% of the vaccinees, and the GM of levels of IgG against OMVs rose to about 14- fold the prevaccination level. One year later, the IgG antibody levels had dropped to 4.6-fold the prevaccination level, but 88% of the vaccinees still showed bactericidal activity. The response after the two first doses was higher in individuals with prevaccination antibodies, but no such effect was found after three doses. The use of defined mutants in SBA and linear multiple regression analyses indicated that among the major OMPs, antibodies to the Opc and class 1 proteins made the most important single contributions to the bactericidal activity against the vaccine strain, but it also demonstrated the importance of antibodies against other antigens. After three doses, 68% of the vaccinees showed a significant SBA response against a strain lacking both the Opc and the class 1 proteins. Three doses converted almost all subjects to SBA responders and gave higher antibody levels and relatively less serosubtype-specific bactericidal activity than did two doses, probably indicating a broader cross- protection against heterologous strains.


This article has been cited by other articles:

  • Hellerud, B. C., Aase, A., Herstad, T. K., Naess, L. M., Kristiansen, L. H., Troseid, A.-M. S., Harboe, M., Lappegard, K. T., Brandtzaeg, P., Hoiby, E. A., Mollnes, T. E. (2010). Critical Roles of Complement and Antibodies in Host Defense Mechanisms against Neisseria meningitidis as Revealed by Human Complement Genetic Deficiencies. Infect. Immun. 78: 802-809 [Abstract] [Full Text]  
  • Williams, J. N., Skipp, P. J., O'Connor, C. D., Christodoulides, M., Heckels, J. E. (2009). Immunoproteomic Analysis of the Development of Natural Immunity in Subjects Colonized by Neisseria meningitidis Reveals Potential Vaccine Candidates. Infect. Immun. 77: 5080-5089 [Abstract] [Full Text]  
  • Lucidarme, J., Comanducci, M., Findlow, J., Gray, S. J., Kaczmarski, E. B., Guiver, M., Kugelberg, E., Vallely, P. J., Oster, P., Pizza, M., Bambini, S., Muzzi, A., Tang, C. M., Borrow, R. (2009). Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales. J. Clin. Microbiol. 47: 3577-3585 [Abstract] [Full Text]  
  • Foster, R. A., Carlring, J., McKendrick, M. W., Lees, A., Borrow, R., Read, R. C., Heath, A. W. (2009). Evidence of a Functional B-Cell Immunodeficiency in Adults Who Experience Serogroup C Meningococcal Disease. CVI 16: 692-698 [Abstract] [Full Text]  
  • Beernink, P. T., Welsch, J. A., Bar-Lev, M., Koeberling, O., Comanducci, M., Granoff, D. M. (2008). Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein. Infect. Immun. 76: 4232-4240 [Abstract] [Full Text]  
  • Hellerud, B. C., Stenvik, J., Espevik, T., Lambris, J. D., Mollnes, T. E., Brandtzaeg, P. (2008). Stages of Meningococcal Sepsis Simulated In Vitro, with Emphasis on Complement and Toll-Like Receptor Activation. Infect. Immun. 76: 4183-4189 [Abstract] [Full Text]  
  • Steeghs, L., Keestra, A. M., van Mourik, A., Uronen-Hansson, H., van der Ley, P., Callard, R., Klein, N., van Putten, J. P. M. (2008). Differential Activation of Human and Mouse Toll-Like Receptor 4 by the Adjuvant Candidate LpxL1 of Neisseria meningitidis. Infect. Immun. 76: 3801-3807 [Abstract] [Full Text]  
  • Norheim, G., Aseffa, A., Yassin, M. A., Mengistu, G., Kassu, A., Fikremariam, D., Tamire, W., Merid, Y., Hoiby, E. A., Caugant, D. A., Fritzsonn, E., Tangen, T., Melak, B., Berhanu, D., Harboe, M., Kolberg, J., Rosenqvist, E. (2008). Specificity of Subcapsular Antibody Responses in Ethiopian Patients following Disease Caused by Serogroup A Meningococci. CVI 15: 863-871 [Abstract] [Full Text]  
  • Plested, J. S., Granoff, D. M. (2008). Vaccine-Induced Opsonophagocytic Immunity to Neisseria meningitidis Group B. CVI 15: 799-804 [Abstract] [Full Text]  
  • Sorhouet Pereira, C., Regueira, M., Mollerach, M. (2008). PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine. J Med Microbiol 57: 338-342 [Abstract] [Full Text]  
  • Arenas, J., Abel, A., Sanchez, S., Marzoa, J., Berron, S., van der Ley, P., Criado, M.-T., Ferreiros, C. M. (2008). A cross-reactive neisserial antigen encoded by the NMB0035 locus shows high sequence conservation but variable surface accessibility. J Med Microbiol 57: 80-87 [Abstract] [Full Text]  
  • Weynants, V. E., Feron, C. M., Goraj, K. K., Bos, M. P., Denoel, P. A., Verlant, V. G., Tommassen, J., Peak, I. R. A., Judd, R. C., Jennings, M. P., Poolman, J. T. (2007). Additive and Synergistic Bactericidal Activity of Antibodies Directed against Minor Outer Membrane Proteins of Neisseria meningitidis. Infect. Immun. 75: 5434-5442 [Abstract] [Full Text]  
  • Findlow, J., Holland, A., Andrews, N., Weynants, V., Sotolongo, F., Balmer, P., Poolman, J., Borrow, R. (2007). Comparison of Phenotypically Indistinguishable but Geographically Distinct Neisseria meningitidis Group B Isolates in a Serum Bactericidal Antibody Assay. CVI 14: 1451-1457 [Abstract] [Full Text]  
  • Hosking, J., Rasanathan, K., Mow, F. C., Jackson, C., Martin, D., O'Hallahan, J., Oster, P., Ypma, E., Reid, S., Aaberge, I., Crengle, S., Stewart, J., Lennon, D. (2007). Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens. CVI 14: 1393-1399 [Abstract] [Full Text]  
  • Sandbu, S., Feiring, B., Oster, P., Helland, O. S., Bakke, H. S. W., Naess, L. M., Aase, A., Aaberge, I. S., Kristoffersen, A.-C., Rydland, K. M., Tilman, S., Nokleby, H., Rosenqvist, E. (2007). Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines. CVI 14: 1062-1069 [Abstract] [Full Text]  
  • Wedege, E., Bolstad, K., Aase, A., Herstad, T. K., McCallum, L., Rosenqvist, E., Oster, P., Martin, D. (2007). Functional and Specific Antibody Responses in Adult Volunteers in New Zealand Who Were Given One of Two Different Meningococcal Serogroup B Outer Membrane Vesicle Vaccines. CVI 14: 830-838 [Abstract] [Full Text]  
  • Williams, J. N., Skipp, P. J., Humphries, H. E., Christodoulides, M., O'Connor, C. D., Heckels, J. E. (2007). Proteomic Analysis of Outer Membranes and Vesicles from Wild-Type Serogroup B Neisseria meningitidis and a Lipopolysaccharide-Deficient Mutant. Infect. Immun. 75: 1364-1372 [Abstract] [Full Text]  
  • Estabrook, M. M., Jarvis, G. A., McLeod Griffiss, J. (2007). Affinity-Purified Human Immunoglobulin G That Binds a Lacto-N-Neotetraose-Dependent Lipooligosaccharide Structure Is Bactericidal for Serogroup B Neisseria meningitidis. Infect. Immun. 75: 1025-1033 [Abstract] [Full Text]  
  • Boutriau, D., Poolman, J., Borrow, R., Findlow, J., Domingo, J. D., Puig-Barbera, J., Baldo, J. M., Planelles, V., Jubert, A., Colomer, J., Gil, A., Levie, K., Kervyn, A.-D., Weynants, V., Dominguez, F., Barbera, R., Sotolongo, F. (2007). Immunogenicity and Safety of Three Doses of a Bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) Meningococcal Outer Membrane Vesicle Vaccine in Healthy Adolescents. CVI 14: 65-73 [Abstract] [Full Text]  
  • Li, Y., Zhang, Q., Winterbotham, M., Mowe, E., Gorringe, A., Tang, C. M. (2006). Immunization with Live Neisseria lactamica Protects Mice against Meningococcal Challenge and Can Elicit Serum Bactericidal Antibodies. Infect. Immun. 74: 6348-6355 [Abstract] [Full Text]  
  • Findlow, J., Taylor, S., Aase, A., Horton, R., Heyderman, R., Southern, J., Andrews, N., Barchha, R., Harrison, E., Lowe, A., Boxer, E., Heaton, C., Balmer, P., Kaczmarski, E., Oster, P., Gorringe, A., Borrow, R., Miller, E. (2006). Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac. Infect. Immun. 74: 4557-4565 [Abstract] [Full Text]  
  • Feiring, B., Fuglesang, J., Oster, P., Naess, L. M., Helland, O. S., Tilman, S., Rosenqvist, E., Bergsaker, M. A. R., Nokleby, H., Aaberge, I. S. (2006). Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine. CVI 13: 790-796 [Abstract] [Full Text]  
  • Toropainen, M., Saarinen, L., Vidarsson, G., Kayhty, H. (2006). Protection by Meningococcal Outer Membrane Protein PorA-Specific Antibodies and a Serogroup B Capsular Polysaccharide-Specific Antibody in Complement-Sufficient and C6-Deficient Infant Rats. Infect. Immun. 74: 2803-2808 [Abstract] [Full Text]  
  • Martin, D. R., Ruijne, N., McCallum, L., O'Hallahan, J., Oster, P. (2006). The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB. CVI 13: 486-491 [Abstract] [Full Text]  
  • Cantini, F., Savino, S., Scarselli, M., Masignani, V., Pizza, M., Romagnoli, G., Swennen, E., Veggi, D., Banci, L., Rappuoli, R. (2006). Solution Structure of the Immunodominant Domain of Protective Antigen GNA1870 of Neisseria meningitidis. J. Biol. Chem. 281: 7220-7227 [Abstract] [Full Text]  
  • Harrison, L. H. (2006). Prospects for Vaccine Prevention of Meningococcal Infection. Clin. Microbiol. Rev. 19: 142-164 [Abstract] [Full Text]  
  • Borrow, R., Aaberge, I. S., Santos, G. F., Eudey, T. L., Oster, P., Glennie, A., Findlow, J., Hoiby, E. A., Rosenqvist, E., Balmer, P., Martin, D. (2005). Interlaboratory Standardization of the Measurement of Serum Bactericidal Activity by Using Human Complement against Meningococcal Serogroup B, Strain 44/76-SL, before and after Vaccination with the Norwegian MenBvac Outer Membrane Vesicle Vaccine. CVI 12: 970-976 [Abstract] [Full Text]  
  • Aaberge, I. S., Oster, P., Helland, O. S., Kristoffersen, A.-C., Ypma, E., Hoiby, E. A., Feiring, B., Nokleby, H. (2005). Combined Administration of Meningococcal Serogroup B Outer Membrane Vesicle Vaccine and Conjugated Serogroup C Vaccine Indicated for Prevention of Meningococcal Disease Is Safe and Immunogenic. CVI 12: 599-605 [Abstract] [Full Text]  
  • Vicente, D., Esnal, O., Michaus, L., Lopez de Goicoechea, M. J., Cisterna, R., Perez-Trallero, E. (2005). Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003. J Med Microbiol 54: 381-384 [Abstract] [Full Text]  
  • Jordens, J. Z., Williams, J. N., Jones, G. R., Christodoulides, M., Heckels, J. E. (2004). Development of Immunity to Serogroup B Meningococci during Carriage of Neisseria meningitidis in a Cohort of University Students. Infect. Immun. 72: 6503-6510 [Abstract] [Full Text]  
  • O'Dwyer, C. A., Reddin, K., Martin, D., Taylor, S. C., Gorringe, A. R., Hudson, M. J., Brodeur, B. R., Langford, P. R., Kroll, J. S. (2004). Expression of Heterologous Antigens in Commensal Neisseria spp.: Preservation of Conformational Epitopes with Vaccine Potential. Infect. Immun. 72: 6511-6518 [Abstract] [Full Text]  
  • Urwin, R., Russell, J. E., Thompson, E. A. L., Holmes, E. C., Feavers, I. M., Maiden, M. C. J. (2004). Distribution of Surface Protein Variants among Hyperinvasive Meningococci: Implications for Vaccine Design. Infect. Immun. 72: 5955-5962 [Abstract] [Full Text]  
  • Ovstebo, R., Brandtzaeg, P., Brusletto, B., Haug, K. B. F., Lande, K., Hoiby, E. A., Kierulf, P. (2004). Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal Disease. J. Clin. Microbiol. 42: 2980-2987 [Abstract] [Full Text]  
  • Alcala, B., Salcedo, C., Arreaza, L., Abad, R., Enriquez, R., De La Fuente, L., Uria, M. J., Vazquez, J. A. (2004). Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain. J Med Microbiol 53: 515-518 [Abstract] [Full Text]  
  • Guthrie, T., Wong, S. Y. C., Liang, B., Hyland, L., Hou, S., Hoiby, E. A., Andersen, S. R. (2004). Local and Systemic Antibody Responses in Mice Immunized Intranasally with Native and Detergent-Extracted Outer Membrane Vesicles from Neisseria meningitidis. Infect. Immun. 72: 2528-2537 [Abstract] [Full Text]  
  • Michaelsen, T. E., Ihle, O., Beckstrom, K. J., Herstad, T. K., Kolberg, J., Hoiby, E. A., Aase, A. (2003). Construction and Functional Activities of Chimeric Mouse-Human Immunoglobulin G and Immunoglobulin M Antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 Epitopes. Infect. Immun. 71: 5714-5723 [Abstract] [Full Text]  
  • Arigita, C., Bevaart, L., Everse, L. A., Koning, G. A., Hennink, W. E., Crommelin, D. J. A., van de Winkel, J. G. J., van Vugt, M. J., Kersten, G. F. A., Jiskoot, W. (2003). Liposomal Meningococcal B Vaccination: Role of Dendritic Cell Targeting in the Development of a Protective Immune Response. Infect. Immun. 71: 5210-5218 [Abstract] [Full Text]  
  • Wedege, E., Kuipers, B., Bolstad, K., van Dijken, H., Froholm, L. O., Vermont, C., Caugant, D. A., van den Dobbelsteen, G. (2003). Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine. Infect. Immun. 71: 3775-3781 [Abstract] [Full Text]  
  • Thompson, E. A. L., Feavers, I. M., Maiden, M. C. J. (2003). Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149: 1849-1858 [Abstract] [Full Text]  
  • Moe, G. R., Zuno-Mitchell, P., Hammond, S. N., Granoff, D. M. (2002). Sequential Immunization with Vesicles Prepared from Heterologous Neisseria meningitidis Strains Elicits Broadly Protective Serum Antibodies to Group B Strains. Infect. Immun. 70: 6021-6031 [Abstract] [Full Text]  
  • Janakova, L., Bakke, H., Haugen, I. L., Berstad, A. K. H., Hoiby, E. A., Aaberge, I. S., Haneberg, B. (2002). Influence of Intravenous Anesthesia on Mucosal and Systemic Antibody Responses to Nasal Vaccines. Infect. Immun. 70: 5479-5484 [Abstract] [Full Text]  
  • Urwin, R., Holmes, E. C., Fox, A. J., Derrick, J. P., Maiden, M. C. J. (2002). Phylogenetic Evidence for Frequent Positive Selection and Recombination in the Meningococcal Surface Antigen PorB. Mol Biol Evol 19: 1686-1694 [Abstract] [Full Text]  
  • Wright, J. C., Williams, J. N., Christodoulides, M., Heckels, J. E. (2002). Immunization with the Recombinant PorB Outer Membrane Protein Induces a Bactericidal Immune Response against Neisseria meningitidis. Infect. Immun. 70: 4028-4034 [Abstract] [Full Text]  
  • Drogari-Apiranthitou, M., Kuijper, E. J., Dekker, N., Dankert, J. (2002). Complement Activation and Formation of the Membrane Attack Complex on Serogroup B Neisseria meningitidis in the Presence or Absence of Serum Bactericidal Activity. Infect. Immun. 70: 3752-3758 [Abstract] [Full Text]  
  • Granoff, D. M., Moe, G. R., Giuliani, M. M., Adu-Bobie, J., Santini, L., Brunelli, B., Piccinetti, F., Zuno-Mitchell, P., Lee, S. S., Neri, P., Bracci, L., Lozzi, L., Rappuoli, R. (2001). A Novel Mimetic Antigen Eliciting Protective Antibody to Neisseria meningitidis. J. Immunol. 167: 6487-6496 [Abstract] [Full Text]  
  • Bakke, H., Lie, K., Haugen, I. L., Korsvold, G. E., Hoiby, E. A., Nass, L. M., Holst, J., Aaberge, I. S., Oftung, F., Haneberg, B. (2001). Meningococcal Outer Membrane Vesicle Vaccine Given Intranasally Can Induce Immunological Memory and Booster Responses without Evidence of Tolerance. Infect. Immun. 69: 5010-5015 [Abstract] [Full Text]  
  • Sacchi, C. T., Lemos, A. P. S., Popovic, T., Cassio de Morais, J., Whitney, A. M., Melles, C. E. A., Brondi, L. M. G., Monteiro, L. M. C., Paiva, M. V., Solari, C. A., Mayer, L. W. (2001). Serosubtypes and PorA Types of Neisseria meningitidis Serogroup B Isolated in Brazil during 1997-1998: Overview and Implications for Vaccine Development. J. Clin. Microbiol. 39: 2897-2903 [Abstract] [Full Text]  
  • Jolley, K. A., Appleby, L., Wright, J. C., Christodoulides, M., Heckels, J. E. (2001). Immunization with Recombinant Opc Outer Membrane Protein from Neisseria meningitidis: Influence of Sequence Variation and Levels of Expression on the Bactericidal Immune Response against Meningococci. Infect. Immun. 69: 3809-3816 [Abstract] [Full Text]  
  • Tondella, M. L. C., Popovic, T., Rosenstein, N. E., Lake, D. B., Carlone, G. M., Mayer, L. W., Perkins, B. A., The Active Bacterial Core Surveillance Team, (2000). Distribution of Neisseria meningitidis Serogroup B Serosubtypes and Serotypes Circulating in the United States. J. Clin. Microbiol. 38: 3323-3328 [Abstract] [Full Text]  
  • Mountzouros, K. T., Howell, A. P. (2000). Detection of Complement-Mediated Antibody-Dependent Bactericidal Activity in a Fluorescence-Based Serum Bactericidal Assay for Group B Neisseria meningitidis. J. Clin. Microbiol. 38: 2878-2884 [Abstract] [Full Text]  
  • Plested, J. S., Makepeace, K., Jennings, M. P., Gidney, M. A. J., Lacelle, S., Brisson, J.-R., Cox, A. D., Martin, A., Bird, A. G., Tang, C. M., Mackinnon, F. M., Richards, J. C., Moxon, E. R. (1999). Conservation and Accessibility of an Inner Core Lipopolysaccharide Epitope of Neisseria meningitidis. Infect. Immun. 67: 5417-5426 [Abstract] [Full Text]  
  • Pollard, A. J., Galassini, R., Rouppe van der Voort, E. M., Booy, R., Langford, P., Nadel, S., Ison, C., Kroll, J. S., Poolman, J., Levin, M. (1999). Humoral Immune Responses to Neisseria meningitidis in Children. Infect. Immun. 67: 2441-2451 [Abstract] [Full Text]  
  • Lehmann, A. K., Halstensen, A., Aaberge, I. S., Holst, J., Michaelsen, T. E., Sornes, S., Wetzler, L. M., Guttormsen, H.-K. (1999). Human Opsonins Induced during Meningococcal Disease Recognize Outer Membrane Proteins PorA and PorB. Infect. Immun. 67: 2552-2560 [Abstract] [Full Text]  
  • Tappero, J. W., Lagos, R., Maldonado Ballesteros, A., Plikaytis, B., Williams, D., Dykes, J., Gheesling, L. L., Carlone, G. M., Hoiby, E. A., Holst, J., Nokleby, H., Rosenqvist, E., Sierra, G., Campa, C., Sotolongo, F., Vega, J., Garcia, J., Herrera, P., Poolman, J. T., Perkins, B. A. (1999). Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines: A Randomized Controlled Trial in Chile. JAMA 281: 1520-1527 [Abstract] [Full Text]  
  • Rosenqvist, E., Musacchio, A., Aase, A., Hoiby, E. A., Namork, E., Kolberg, J., Wedege, E., Delvig, A., Dalseg, R., Michaelsen, T. E., Tommassen, J. (1999). Functional Activities and Epitope Specificity of Human and Murine Antibodies against the Class 4 Outer Membrane Protein (Rmp) of Neisseria meningitidis. Infect. Immun. 67: 1267-1276 [Abstract] [Full Text]  
  • Oftung, F., Nass, L. M., Wetzler, L. M., Korsvold, G. E., Aase, A., Hoiby, E. A., Dalseg, R., Holst, J., Michaelsen, T. E., Haneberg, B. (1999). Antigen-Specific T-Cell Responses in Humans after Intranasal Immunization with a Meningococcal Serogroup B Outer Membrane Vesicle Vaccine. Infect. Immun. 67: 921-927 [Abstract] [Full Text]  
  • Milagres, L. G., Gorla, M. C. A., Sacchi, C. T., Rodrigues, M. M. (1998). Specificity of Bactericidal Antibody Response to Serogroup B Meningococcal Strains in Brazilian Children after Immunization with an Outer Membrane Vaccine. Infect. Immun. 66: 4755-4761 [Abstract] [Full Text]  
  • Wedege, E., Hoiby, E. A., Rosenqvist, E., Bjune, G. (1998). Immune Responses against Major Outer Membrane Antigens of Neisseria meningitidis in Vaccinees and Controls Who Contracted Meningococcal Disease during the Norwegian Serogroup B Protection Trial. Infect. Immun. 66: 3223-3231 [Abstract] [Full Text]  
  • Haneberg, B., Dalseg, R., Wedege, E., Hoiby, E. A., Haugen, I. L., Oftung, F., Andersen, S. R., Nass, L. M., Aase, A., Michaelsen, T. E., Holst, J. (1998). Intranasal Administration of a Meningococcal Outer Membrane Vesicle Vaccine Induces Persistent Local Mucosal Antibodies and Serum Antibodies with Strong Bactericidal Activity in Humans. Infect. Immun. 66: 1334-1341 [Abstract] [Full Text]  
  • Nass, L. M., Oftung, F., Aase, A., Wetzler, L. M., Sandin, R., Michaelsen, T. E. (1998). Human T-Cell Responses after Vaccination with the Norwegian Group B Meningococcal Outer Membrane Vesicle Vaccine. Infect. Immun. 66: 959-965 [Abstract] [Full Text]  
  • Velucchi, M., Rustici, A., Meazza, C., Villa, P., Ghezzi, P., Tsai, C-M., Porro, M. (1997). A model of Neisseria meningitidis vaccine based on LPS micelles detoxified by synthetic antiendotoxin peptides. Innate Immunity 4: 261-272 [Abstract]  
  • Demitri, M.T., Velucchi, M., Bracci, L., Rustici, A., Porro, M., Villa, P., Ghezzi, P. (1996). Inhibition of LPS-induced systemic and local TNF production by a synthetic anti-endotoxin peptide (SAEP-2). Innate Immunity 3: 445-454 [Abstract]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»